AP

Amylyx Pharmaceuticals

healthtech
Public / Late-stage
Cambridge

About

Biopharmaceutical company developing therapies; reported positive late-stage trial results for a drug reducing dangerous low blood-sugar episodes in bariatric surgery patients.

Recent News